GeneDx Holdings Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 26, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	2,073	3,759	2,111	71	102	1,076
Market Cap Growth	4.51%	78.05%	2866.28%	-30.24%	-90.52%	-94.66%
Enterprise Value	2,070	3,717	2,111	31	-11	648
Last Close Price	69.82	130.06	76.86	2.75	8.71	147.18
Forward PE	168.57	-	190.96	-	-	-
PS Ratio	4.68	8.79	6.91	0.35	0.44	5.07
PB Ratio	8.15	12.20	8.61	0.31	0.40	2.77
P/TBV Ratio	19.28	29.79	24.37	1.29	1.52	2.77
P/FCF Ratio	-	263.59	-	-	-	-
P/OCF Ratio	-	112.96	-	-	-	-
EV/Sales Ratio	4.68	8.70	6.91	0.15	-	3.06
EV/EBITDA Ratio	-	293.82	-	-	-	-
EV/FCF Ratio	-	260.65	-	-	-	-
Debt / Equity Ratio	0.66	0.37	0.48	0.52	0.30	0.03
Debt / EBITDA Ratio	364.84	5.46	23.55	-	-	-
Debt / FCF Ratio	-	7.94	-	-	-	-
Net Debt / Equity Ratio	-0.01	-0.19	-0.10	-0.05	-0.18	-1.00
Net Debt / EBITDA Ratio	0.32	-4.59	11.30	0.08	0.11	0.91
Net Debt / FCF Ratio	0.09	-4.07	0.70	0.06	0.14	1.95
Asset Turnover	0.93	0.91	0.73	0.45	0.45	0.53
Inventory Turnover	10.82	10.52	11.43	10.02	11.10	7.83
Quick Ratio	2.83	2.26	3.26	2.77	1.17	4.22
Current Ratio	3.09	2.46	3.61	3.10	1.47	4.77
Return on Equity (ROE)	-30.42%	-7.60%	-22.10%	-72.97%	-171.07%	-125.04%
Return on Assets (ROA)	-4.37%	-1.55%	-3.45%	-23.37%	-54.72%	-69.21%
Return on Capital Employed (ROCE)	-8.00%	-2.80%	-6.40%	-47.20%	-132.00%	-98.50%
Earnings Yield	-3.75%	-0.56%	-2.48%	-246.93%	-538.02%	-22.80%
FCF Yield	-1.38%	0.38%	-1.61%	-260.46%	-319.80%	-18.57%
Buyback Yield / Dilution	-5.57%	-6.51%	-10.61%	-137.49%	-212.57%	-

SEC Filings: 10-K · 10-Q